Myriad Genetics Inc (NAS:MYGN)
$ 26.835 0.445 (1.69%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Myriad Genetics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 07:50PM GMT
Release Date Price: $25.44 (+5.21%)
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

Hi, everyone, welcome to the 2021 JPMorgan Healthcare Conference. My name is Casey Woodring and I'm a member of the life science tools and diagnostics equity research team here at JPMorgan. Today, it's my pleasure to introduce the management team from Myriad Genetics. As a reminder, if you would like to ask a question, please feel free to submit via the presentation web page. And with that, let me turn it over to Paul.

Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

Great. Thank you, Casey. Thank the whole JPMorgan team, Tycho and the rest of the team, for allowing us the opportunity to present here today. And let me send a shout-out to all of my teammates at Myriad Genetics for their incredible efforts over the last few months of continuing to manage through this pandemic and how hard everyone is working to be responsive to our patients' needs.

We are excited today to give everyone an update of our transformation plan. And the progress that we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot